Portfolio company
FAST Biomedical
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops medical technology for measuring blood volume and kidney function to assist healthcare professionals treating heart failure and sepsis patients.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Advanced Perfusion Diagnostics
This company develops single-use devices for non-invasive, continuous microcirculation assessment and early sepsis detection for clinicians in critical care and surgical settings.
410 Medical
This company develops handheld rapid infusion devices to deliver fluids and blood to critically ill patients for hospitals and emergency medical services.
SepsiScan
This company develops bedside imaging devices for real-time microcirculation monitoring and early sepsis diagnosis for intensive care units and hospitals.
PATH EX, Inc.
This company develops a medical device that removes bacteria and endotoxins from the bloodstream to treat sepsis patients in clinical settings.
Noninvasix
This company develops non-invasive optoacoustic monitoring technology to measure central venous oxygenation levels for clinicians treating patients with sepsis and septic shock.
Sonavex
This medical technology company develops automated ultrasound devices and bioresorbable markers for dialysis clinics and surgical teams to monitor vascular access and blood flow.
Hemotune
This company develops a magnetic blood purification platform using nanoengineered beads to remove specific disease-causing substances for patients with sepsis or requiring gene therapy.
iFAST Diagnositcs
The company develops rapid antimicrobial susceptibility testing systems for hospitals and clinical laboratories to identify effective antibiotic treatments for bacterial infections.
